<DOC>
	<DOCNO>NCT00695071</DOCNO>
	<brief_summary>The objective clinical trial document steady state pharmacokinetics safety new itraconazole 200 mg film coat tablet .</brief_summary>
	<brief_title>Study Assess Blood Levels Itraconazole During Two-Week Period</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>BMI 18.0 28.0 kg/m2 Good physical mental health status , determine basis medical history general clinical examination . Vital sign ( blood pressure heart rate ) supine position within normal range Electrocardiogram ( 12 lead ) consider normal Nonsmoker . Able swallow pill If subject woman childbearing potential ( WOCBP ) , must agree use adequate birth control define protocol Any disease physical condition , opinion investigator , could impact pharmacokinetics drug History presence drug abuse consumption alcohol History sensitivity allergy azoles relate drug Any requirement drug treatment ( except acetaminophen WOCBP , hormonal contraceptive ) Unsuitable vein repeat venipuncture . Clinically significant abnormal ECG Nursing mother pregnant woman , woman childbearing potential use adequate contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>